Search Results - "Samoylova, Olga"

Venetoclax and Obinutuzumab in Patients with CLL and Coexisting Conditions by Fischer, Kirsten, Al-Sawaf, Othman, Bahlo, Jasmin, Fink, Anna-Maria, Tandon, Maneesh, Dixon, Mark, Robrecht, Sandra, Warburton, Simon, Humphrey, Kathryn, Samoylova, Olga, Liberati, Anna M, Pinilla-Ibarz, Javier, Opat, Stephen, Sivcheva, Liliya, Le Dû, Katell, Fogliatto, Laura M, Niemann, Carsten U, Weinkove, Robert, Robinson, Sue, Kipps, Thomas J, Boettcher, Sebastian, Tausch, Eugen, Humerickhouse, Rod, Eichhorst, Barbara, Wendtner, Clemens-Martin, Langerak, Anton W, Kreuzer, Karl-Anton, Ritgen, Matthias, Goede, Valentin, Stilgenbauer, Stephan, Mobasher, Mehrdad, Hallek, Michael

“…The combination of the BCL2 inhibitor venetoclax plus obinutuzumab was more effective in the treatment of older medically ill patients with untreated chronic…”
Get full text

Obinutuzumab plus Chlorambucil in Patients with CLL and Coexisting Conditions by Goede, Valentin, Fischer, Kirsten, Busch, Raymonde, Engelke, Anja, Eichhorst, Barbara, Wendtner, Clemens M, Chagorova, Tatiana, de la Serna, Javier, Dilhuydy, Marie-Sarah, Illmer, Thomas, Opat, Stephen, Owen, Carolyn J, Samoylova, Olga, Kreuzer, Karl-Anton, Stilgenbauer, Stephan, Döhner, Hartmut, Langerak, Anton W, Ritgen, Matthias, Kneba, Michael, Asikanius, Elina, Humphrey, Kathryn, Wenger, Michael, Hallek, Michael

“…Obinutuzumab, a glycoengineered anti-CD20 antibody with increased killing capacity, outperformed rituximab when used in combination with chlorambucil in…”
Get full text

Molecular Dynamics Simulations of Ion Transport in Carbon Nanotube Channels by Samoylova, Olga N, Calixte, Emvia I, Shuford, Kevin L

“…We present a computational modeling study examining ion transport dynamics of aqueous electrolytes under severely confined conditions. Ionic current and…”
Get full text

Evaluation of the QTc prolongation potential of a monoclonal antibody, siltuximab, in patients with monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, or low-volume multiple myeloma by Thomas, Sheeba K., Suvorov, Alexander, Noens, Lucien, Rukavitsin, Oleg, Fay, Joseph, Wu, Ka Lung, Zimmerman, Todd M., van de Velde, Helgi, Bandekar, Rajesh, Puchalski, Thomas A., Qi, Ming, Uhlar, Clarissa, Samoylova, Olga S.

“…Purpose A phase 1 study evaluated the QTc prolongation potential of siltuximab, a chimeric, anti-interleukin-6 mAb, in patients with monoclonal gammopathy of…”
Get full text

Selective ion transport in functionalized carbon nanotubes by Samoylova, Olga N., Calixte, Emvia I., Shuford, Kevin L.

“…[Display omitted] •MD simulations show ion transport within nanotubes is enhanced via functionalization.•Dramatic increases in current result from appropriate…”
Get full text

Venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab for previously untreated chronic lymphocytic leukaemia (CLL14): follow-up results from a multicentre, open-label, randomised, phase 3 trial by Al-Sawaf, Othman, Zhang, Can, Tandon, Maneesh, Sinha, Arijit, Fink, Anna-Maria, Robrecht, Sandra, Samoylova, Olga, Liberati, Anna M, Pinilla-Ibarz, Javier, Opat, Stephen, Sivcheva, Liliya, Le Dû, Katell, Fogliatto, Laura M, Niemann, Carsten U, Weinkove, Robert, Robinson, Sue, Kipps, Thomas J, Tausch, Eugen, Schary, William, Ritgen, Matthias, Wendtner, Clemens-Martin, Kreuzer, Karl-Anton, Eichhorst, Barbara, Stilgenbauer, Stephan, Hallek, Michael, Fischer, Kirsten

“…Venetoclax plus obinutuzumab has been established as a fixed-duration treatment regimen for patients with chronic lymphocytic leukaemia. We compared the…”
Get full text

Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in adults with haematological malignancies: a phase 3, randomised, clinical trial and post-hoc efficacy analysis by Dagnew, Alemnew F, Ilhan, Osman, Lee, Won-Sik, Woszczyk, Dariusz, Kwak, Jae-Yong, Bowcock, Stella, Sohn, Sang Kyun, Rodriguez Macías, Gabriela, Chiou, Tzeon-Jye, Quiel, Dimas, Aoun, Mickael, Navarro Matilla, Maria Belen, de la Serna, Javier, Milliken, Samuel, Murphy, John, McNeil, Shelly A, Salaun, Bruno, Di Paolo, Emmanuel, Campora, Laura, López-Fauqued, Marta, El Idrissi, Mohamed, Schuind, Anne, Heineman, Thomas C, Van den Steen, Peter, Oostvogels, Lidia, Acar, Kadir, Afanasyev, Boris, Alonso Alonso, Aránzazu, Anttila, Veli-Jukka, Barba Suñol, Pere, Blesing, Norbert, Comeau, Terrance, del Campo, Teresa, Disperati, Patricia, Eek, Richard, Eom, HyeonSeok, Gaidano, Gianluca, Grosicki, Sebastian, Guillaume, Thierry, Homenda, Wojciech, Hwang, William, Ilyin, Nikolay, Johnston, Anna, Kim, Seok Jin, Kuo, Ching-Yuan, Kuvshinov, Aleksey, Lee, Dong-Gun, Lee, Jae Hoon, Lee, Je-Jung, Lepretre, Stephane, Lie, Albert Kwok-Wai, Lucchesi, Alessandro, Masood, Ahmed, Mir, Naheed, Miranda Castillo, Anna Carolina, Mullane, Kathleen, Myasnikov, Alexandr, Oña Navarrete, Raquel, Pauksens, Karlis, Peniket, Andrew, Perez de Oteyza, Jaime, Pohlreich, David, Pullon, Humphrey, Quittet, Philippe, Rodon, Philippe, Rombo, Lars, Samoylova, Olga, Sanmartin Berglund, Johan, Schattner, Ariah, Selleslag, Dominik, Sinisalo, Marjatta, Sultan, Faisal, Theunissen, Koen, Turner, Paul, Wang, Po-Nan, Yáñez San Segundo, Lucrecia, Young, Jo-Anne, Zachee, Pierre, Zaja, Francesco

“…The adjuvanted recombinant zoster vaccine (Shingrix) can prevent herpes zoster in older adults and autologous haemopoietic stem cell transplant recipients. We…”
Get full text

Selective ion transport in functionalized carbon nanotubes by Samoylova, Olga N., Calixte, Emvia I., Shuford, Kevin L.

“…Not provided…”
Get full text

Non-Intensive Continuous Treatment with a Tyrosine Kinase Inhibitor (TKI) Followed By Allo-HSCT Is an Effective Therapeutic Strategy for Adult Ph-Positive Acute Lymphoblastic Leukemia: Outcomes of the Russian Prospective Multicenter RALL Study by Gavrilina, Olga A., Parovichnikova, Elena N., Troitskaya, Vera V., Akhmerzaeva, Zalina Kh, Bondarenko, Sergey N., Lapin, Valery A., Grishunina, Maria E., Samoylova, Olga S., Konstantinova, Tatiana S., Kuzmina, Larisa A., Chabaeva, Julia A., Savchenko, Valery G.

“…Introduction. As Ph-positive (Ph+) ALL in adults remains less favorable in prognosis than other ALL, and by expert opinion needs non-intensive chemotherapy…”
Get full text

A phase 2, randomized, double‐blind, placebo‐controlled study of siltuximab (anti‐IL‐6 mAb) and bortezomib versus bortezomib alone in patients with relapsed or refractory multiple myeloma by Orlowski, Robert Z., Gercheva, Liana, Williams, Cathy, Sutherland, Heather, Robak, Tadeusz, Masszi, Tamás, Goranova‐Marinova, Vesselina, Dimopoulos, Meletios A., Cavenagh, James D., Špička, Ivan, Maiolino, Angelo, Suvorov, Alexander, Bladé, Joan, Samoylova, Olga, Puchalski, Thomas A., Reddy, Manjula, Bandekar, Rajesh, van de Velde, Helgi, Xie, Hong, Rossi, Jean‐Franςois

“…We compared the safety and efficacy of siltuximab (S), an anti‐interleukin‐6 chimeric monoclonal antibody, plus bortezomib (B) with placebo (plc) + B in…”
Get full text

Carfilzomib, dexamethasone and daratumumab in relapsed or refractory multiple myeloma: results of the phase III study CANDOR by prior lines of therapy by Quach, Hang, Nooka, Ajay, Samoylova, Olga, Venner, Christopher P., Kim, Kihyun, Facon, Thierry, Spencer, Andrew, Usmani, Saad Z., Grosicki, Sebastian, Suzuki, Kenshi, Delimpasi, Sosana, Weisel, Katja, Obreja, Mihaela, Zahlten‐Kumeli, Anita, Mateos, Maria‐Victoria

Get full text

Lisaftoclax (APG-2575) Safety and Activity As Monotherapy or Combined with Acalabrutinib or Rituximab in Patients (pts) with Treatment-Naïve, Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (R/R CLL/SLL): Initial Data from a Phase 2 Global Study by Davids, Matthew S., Chanan-Khan, Asher, Mudenda, Boyd, Nogaieva, Larysa, Kriachok, Iryna, Usenko, Hanna, Ivanov, Vladimir, Kyselova, Olena, Perekhrestenko, Tetiana, Muzhychuk, Ivan, Myasnikov, Alexander, Maslyak, Zvenyslava, Proidakov, Andrew, Uspenskaya, Olga, Borisenkova, Elena, Marlton, Paula, Siddiqi, Tanya, Winter, Allison, Lysa, Tamila, Bakirov, Bulat, Fu, Lei, Chen, Zi, Yu, Min, Li, Mingyu, Glass, Laura, Ahmad, Mohammad, Karpenko, Olena, Osipov, Iurii, De, Asit, Paudyal, Ben, Wang, Hengbang, Winkler, Robert, Gabrail, Nashat, Ganju, Vinod, Konstantinova, Tatiana S., Samoylova, Olga S., Yang, Dajun, Zhai, Yifan

Get full text

Light-activated molecular machines are fast-acting broad-spectrum antibacterials that target the membrane by Santos, Ana L, Liu, Dongdong, Reed, Anna K, Wyderka, Aaron M, van Venrooy, Alexis, Li, John T, Li, Victor D, Misiura, Mikita, Samoylova, Olga, Beckham, Jacob L, Ayala-Orozco, Ciceron, Kolomeisky, Anatoly B, Alemany, Lawrence B, Oliver, Antonio, Tegos, George P, Tour, James M

“…The increasing occurrence of antibiotic-resistant bacteria and the dwindling antibiotic research and development pipeline have created a pressing global health…”
Get full text

Trial in Progress: Phase 1b Study of Lisaftoclax (APG-2575) As a Single Agent or Combined with Other Therapeutic Agents in Patients with Relapsed and/or Refractory Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (R/R CLL/SLL) by Davids, Matthew S., Siddiqi, Tanya, Chanan-Khan, Asher, Skarbnik, Alan, Winter, Allison M., Pagel, John M., Smith, Carrie, Gabrail, Nashat, Perekhrestenko, Tetiana, Pylypenko, Halyna, Kyselova, Olena, Karpenko, Olena, Popovska, Tetiana, Kriachok, Iryna, Usenko, Hanna, Proidakov, Andrew, Ivanov, Vladimir, Lysa, Tamila, Borisenkova, Elena, Bakirov, Bulat, Lukavetsky, Les, Uspenskaya, Olga, Konstantinova, Tatiana S., Samoylova, Olga S., Chen, Zi, Huang, Bo, Li, Mingyu, Ahmad, Mohammad, Mudenda, Boyd, Yang, Dajun, Zhai, Yifan

“…Background: BCL-2 inhibition with venetoclax has proved to be highly effective treatment for patients with CLL. However, when administered to patients with CLL…”
Get full text

Outcomes in Patients with Hematologic Disease and COVID-19 in Russia: Interim Analysis of CHRONOS19 Registry by Gavrilina, Olga A., Zakurdaeva, Kristina, Vorobyev, Vladimir I., Vasileva, Anastasia N., Butaev, Lev S., Sukhareva, Alena, Gavrilova, Lubov, Samoylova, Olga, Grishunina, Maria, Ochirova, Ochsana, Karpova, Alina, Panteleeva, Olga, Kunst, Mikhail A., Shuvaev, Vasily, Rakhmani, Anzhelika, Gaponova, Tatiana V., Galstyan, Gennadiy M., Troitskaya, Vera V., Luchkin, Anton V., Parovichnikova, Elena N., Savchenko, Valery

“…Background: Patients (pts) with hematologic disease are at increased risk of severe SARS-CoV-2 infection. Recent observations reported poor outcomes of…”
Get full text

Implementation experiences and insights from the scale‐up of an HIV assisted partner notification intervention in Central Asia by Little, Kristen M, Kan, Maxim, Samoylova, Olga, Rsaldinova, Altynai, Saliev, Daniyar, Ishokov, Faridun, Gray, Robert, Hasen, Nina S

“…Introduction WHO recommends assisted partner notification (APN) for people living with HIV (PLHIV). These services have not been widely scaled in Central Asia…”
Get full text

Social network methods for HIV case‐finding among people who inject drugs in Tajikistan by Kan, Maxim, Garfinkel, Danielle B, Samoylova, Olga, Gray, Robert P, Little, Kristen M

“…Introduction HIV testing programmes have struggled to reach the most marginalized populations at risk for HIV. Social network methods such as respondent‐driven…”
Get full text

Clinical Outcomes in Patients With COVID-19 and Hematologic Disease by Aleshina, Olga A., Zakurdaeva, Kristina, Vasileva, Anastasia N., Dubov, Sergey K., Dubov, Vitaly S., Vorobyev, Vladimir I., Butaev, Lev S., Sukhareva, Alena M., Gavrilova, Lubov V., Toropova, Inessa Yu, Popova, Marina O., Siniaev, Aleksandr A., Kulagin, Aleksandr D., Kaplanov, Kamil D., Petrenko, Andrei A., Ochirova, Oksana I., Karpova, Alina, Chelysheva, Ekaterina Yu, Turkina, Anna G., Gurianova, Margarita A., Al-Radi, Liubov S., Gilyazitdinova, Elena A., Egorova, Elena K., Chabaeva, Yulia A., Kulikov, Sergey M., Sveshnikova, Yulia V., Kunst, Mikhail A., Shuvaev, Vasily, Rakhmani, Anzhelika F., Panteleeva, Olga L., Grishunina, Maria E., Samoylova, Olga S., Vorontsova, Ekaterina, Baryshnikova, Daria V., Parovichnikova, Elena N.

“…•Patients with hematologic disease and COVID-19 have high all-cause mortality at short-term follow-up, predominantly due to COVID-19 complications.•Patients…”
Get full text

Guiding optical modes in chains of dielectric particles by Blaustein, Gail S, Gozman, Michael I, Samoylova, Olga, Polishchuk, I Ya, Burin, Alexander L

“…We have investigated low frequency guiding polariton modes in finite linear chains of closely packed dielectric spherical particles of different optical…”
Get full text

MM-128: Carfilzomib, Dexamethasone, and Daratumumab (KdD) Versus Carfilzomib and Dexamethasone (Kd) in Relapsed or Refractory Multiple Myeloma (RRMM): Subgroup Analysis of the Phase 3 CANDOR Study by Number of Prior Lines of Therapy (pLOTs) and Prior Therapies by Quach, Hang, Nooka, Ajay, Samoylova, Olga, Venner, Christopher, Kim, Kihyun, Facon, Thierry, Spencer, Andrew, Usmani, Saad, Grosicki, Sebastian, Suzuki, Kenshi, Delimpasi, Sosana, Weisel, Katja, Obreja, Mihaela, Zahlten-Kumeli, Anita, Mateos, Maria-Victoria

“…RRMM requires effective and tolerable treatments, particularly for those exposed or refractory to lenalidomide (LEN) or bortezomib (BOR).The CANDOR trial found…”
Get full text